|
 |
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 44, 254-264, February 2003
Copyright © 2003 by Lipid Research, Inc.
Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2 +5G>C mutation in ABCA1 gene
* Department of Biomedical Sciences, University of Modena and Reggio Emilia
Department of Internal Medicine, University of Genoa
National Institute of Health, Rome
** Department of Pharmacological Sciences, Center "E. Grossi Paoletti," University of Milan
Ospedale Maggiore-IRCCS, Milan
Sant'Anna Hospital, Castelnuovo Monti, Reggio Emilia
*** Departments of Pharmacological, Biological Sciences and Applied Chemistries, University of Parma, Italy
1 To whom correspondence should be addressed. e-mail: sebcal{at}unimo.it
Two point mutations of ABCA1 gene were found in a patient with Tangier disease (TD): i) G>C in intron 2 (IVS2 +5G>C) and ii) c.844 C>T in exon 9 (R282X). The IVS2 +5G>C mutation was also found in the brother of another deceased TD patient, but not in 78 controls and 33 subjects with low HDL. The IVS2 +5G>C mutation disrupts ABCA1 pre-mRNA splicing in fibroblasts, leading to three abnormal mRNAs: devoid of exon 2 (Ex2-/mRNA), exon 4 (Ex4-/mRNA), or both these exons (Ex2-/Ex4-/mRNA), each containing a translation initiation site. These mRNAs are expected either not to be translated or generate short peptides. To investigate the in vitro effect of IVS2 +5G>C mutation, we constructed two ABCA1 minigenes encompassing Ex1–Ex3 region, one with wild-type (WTgene) and the other with mutant (MTgene) intron 2. These minigenes were transfected into COS1 and NIH3T3, two cell lines with a different ABCA1 gene expression. In COS1 cells, WTgene pre-mRNA was spliced correctly, while the splicing of MTgene pre-mRNA resulted in Ex2-/mRNA. In NIH3T3, no splicing of MTgene pre-mRNA was observed, whereas WTgene pre-mRNA was spliced correctly.
These results stress the complexity of ABCA1 pre-mRNA splicing in the presence of splice site mutations.
Supplementary key words ABCA1 minigenes • in vitro splicing • donor splice site mutation
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Schippling, M. Orth, U. Beisiegel, T. Rosenkranz, P. Vogel, A. Munchau, C. Hagel, and U. Seedorf SEVERE TANGIER DISEASE WITH A NOVEL ABCA1 GENE MUTATION Neurology, October 28, 2008; 71(18): 1454 - 1455. [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Pagler, S. Rhode, A. Neuhofer, H. Laggner, W. Strobl, C. Hinterndorfer, I. Volf, M. Pavelka, E. R. M. Eckhardt, D. R. van der Westhuyzen, et al. SR-BI-mediated High Density Lipoprotein (HDL) Endocytosis Leads to HDL Resecretion Facilitating Cholesterol Efflux J. Biol. Chem., April 21, 2006; 281(16): 11193 - 11204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Fasano, L. Bocchi, L. Pisciotta, S. Bertolini, and S. Calandra Denaturing high-performance liquid chromatography in the detection of ABCA1 gene mutations in familial HDL deficiency J. Lipid Res., April 1, 2005; 46(4): 817 - 822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ho Hong, J. Rhyne, and M. Miller Novel Polypyrimidine Variation (IVS46: del T -39...-46) in ABCA1 Causes Exon Skipping and Contributes to HDL Cholesterol Deficiency in a Family With Premature Coronary Disease Circ. Res., November 14, 2003; 93(10): 1006 - 1012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Singaraja, L. R. Brunham, H. Visscher, J. J.P. Kastelein, and M. R. Hayden Efflux and Atherosclerosis: The Clinical and Biochemical Impact of Variations in the ABCA1 Gene Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1322 - 1332. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |